|
| 37178311 | A tribute to Ernest L. Mazzaferri, MD and the lasting impact that he had on thyroid cancer care ten years after his death. | Endocrine | 2023 |
| 35691860 | Molecular testing in thyroid cancer diagnosis and management. | Best Pract Res Clin Endocrinol Metab | 2023 |
| 37051697 | The <i>RCAN1.4</i> Metastasis Suppressor Is Hypermethylated at Intron 1 in Thyroid Cancer. | Thyroid | 2023 |
| 35081743 | Active Surveillance Versus Thyroid Surgery for Differentiated Thyroid Cancer: A Systematic Review. | Thyroid | 2022 |
| 35658604 | Dabrafenib Versus Dabrafenib + Trametinib in <i>BRAF</i>-Mutated Radioactive Iodine Refractory Differentiated Thyroid Cancer: Results of a Randomized, Phase 2, Open-Label Multicenter Trial. | Thyroid | 2022 |
| 35412871 | Serum Thyroglobulin Measurement Following Surgery Without Radioactive Iodine for Differentiated Thyroid Cancer: A Systematic Review. | Thyroid | 2022 |
| 36111274 | Adrenal Near-Infrared Autofluorescence. | J Endocr Soc | 2022 |
| 35274388 | American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining advanced thyroid cancer and its targeted treatment. | Head Neck | 2022 |
| 32327406 | Stromal Platelet-Derived Growth Factor Receptor-β Signaling Promotes Breast Cancer Metastasis in the Brain. | Cancer Res | 2021 |
| 33515756 | Facilitators and Barriers to Nursing Implementation of Continuous Glucose Monitoring (CGM) in Critically Ill Patients With COVID-19. | Endocr Pract | 2021 |
| 34916535 | Author Correction: GWAS of thyroid stimulating hormone highlights the pleiotropic effects and inverse association with thyroid cancer. | Nat Commun | 2021 |
| 34638434 | <i>RAC1</i> Alterations Induce Acquired Dabrafenib Resistance in Association with Anaplastic Transformation in a Papillary Thyroid Cancer Patient. | Cancers (Basel) | 2021 |
| 34100545 | Use of Continuous Glucose Monitor in Critically Ill COVID-19 Patients Requiring Insulin Infusion: An Observational Study. | J Clin Endocrinol Metab | 2021 |
| 34013533 | Thyroid cancer, recent advances in diagnosis and therapy. | Int J Cancer | 2021 |
| 34238982 | Transcriptome analysis discloses dysregulated genes in normal appearing tumor-adjacent thyroid tissues from patients with papillary thyroid carcinoma. | Sci Rep | 2021 |
| 34264856 | Radioiodine: 80 years and counting; the past, present, and future. | Endocr Relat Cancer | 2021 |
| 33449450 | Prevalence of cancer and the benign call rate of afirma gene classifier in [18] F-Fluorodeoxyglucose positron emission tomography positive cytologically indeterminate thyroid nodules. | Cancer Med | 2021 |
| 33393936 | Building on strength. | Endocr Relat Cancer | 2021 |
| 32977343 | New Horizons: Emerging Therapies and Targets in Thyroid Cancer. | J Clin Endocrinol Metab | 2021 |
| 32132206 | Assessing thyroid cancer risk using polygenic risk scores. | Proc Natl Acad Sci U S A | 2020 |
| 33110146 | Akt isoform-specific effects on thyroid cancer development and progression in a murine thyroid cancer model. | Sci Rep | 2020 |
| 32609833 | p21-Activated Kinases in Thyroid Cancer. | Endocrinology | 2020 |
| 32580150 | HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: The state of science in medullary thyroid carcinoma: current challenges and unmet needs. | Endocr Relat Cancer | 2020 |
| 32772084 | Features of Cytologically Indeterminate Molecularly Benign Nodules Treated With Surgery. | J Clin Endocrinol Metab | 2020 |
| 32769997 | GWAS of thyroid stimulating hormone highlights pleiotropic effects and inverse association with thyroid cancer. | Nat Commun | 2020 |
| 32779092 | Progression and dormancy in metastatic thyroid cancer: concepts and clinical implications. | Endocrine | 2020 |
| 30419129 | Performance of a Multigene Genomic Classifier in Thyroid Nodules With Indeterminate Cytology: A Prospective Blinded Multicenter Study. | JAMA Oncol | 2019 |
| 31384713 | Compensation, Productivity, and Other Demographics of Academic Divisions of Endocrinology, Diabetes, and Metabolism. | J Endocr Soc | 2019 |
| 31154940 | Afirma Gene Sequencing Classifier Compared with Gene Expression Classifier in Indeterminate Thyroid Nodules. | Thyroid | 2019 |
| 31097454 | Inhibiting BRAF Oncogene-Mediated Radioresistance Effectively Radiosensitizes BRAF<sup>V600E</sup>-Mutant Thyroid Cancer Cells by Constraining DNA Double-Strand Break Repair. | Clin Cancer Res | 2019 |
| 31146260 | MAPK- and AKT-activated thyroid cancers are sensitive to group I PAK inhibition. | Endocr Relat Cancer | 2019 |
| 31085763 | KRAS G12V Mutation in Acquired Resistance to Combined BRAF and MEK Inhibition in Papillary Thyroid Cancer. | J Natl Compr Canc Netw | 2019 |
| 30820785 | Long-Term Efficacy of Lymph Node Reoperation for Persistent Papillary Thyroid Cancer: 13-Year Follow-Up. | Ann Surg Oncol | 2019 |
| 30545990 | NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018. | J Natl Compr Canc Netw | 2018 |
| 30135308 | Transcriptional targeting of oncogene addiction in medullary thyroid cancer. | JCI Insight | 2018 |
| 30088223 | Neck Ultrasound in Patients with Follicular Thyroid Carcinoma. | Horm Cancer | 2018 |
| 27965276 | Thyroid nodules and cancer management guidelines: comparisons and controversies. | Endocr Relat Cancer | 2017 |
| 28195142 | A genome-wide association study yields five novel thyroid cancer risk loci. | Nat Commun | 2017 |
| 28164237 | Cowden syndrome-associated germline succinate dehydrogenase complex subunit D (SDHD) variants cause PTEN-mediated down-regulation of autophagy in thyroid cancer cells. | Hum Mol Genet | 2017 |
| 28289712 | RCAN1-4 is a thyroid cancer growth and metastasis suppressor. | JCI Insight | 2017 |
| 29132255 | Selected Radiation Safety Aspects Including Transportation and Lodging After Outpatient <sup>131</sup>I Therapy for Differentiated Thyroid Cancer. | Thyroid | 2017 |
| 29105562 | Reduced Retinoblastoma Protein Expression Is Associated with Decreased Patient Survival in Medullary Thyroid Cancer. | Thyroid | 2017 |
| 28510122 | Anti-thyroglobulin antibodies do not significantly increase the risk of finding iodine avid metastases on post-radioactive iodine ablation scan in low-risk thyroid cancer patients. | J Endocrinol Invest | 2017 |
| 28591772 | Biological Evaluation of a Fluorescent-Imaging Agent for Medullary Thyroid Cancer in an Orthotopic Model. | J Clin Endocrinol Metab | 2017 |
| 28687633 | United States and European Multicenter Prospective Study for the Analytical Performance and Clinical Validation of a Novel Sensitive Fully Automated Immunoassay for Calcitonin. | Clin Chem | 2017 |
| 27736322 | Thyroglobulin Liquid Chromatography-Tandem Mass Spectrometry Has a Low Sensitivity for Detecting Structural Disease in Patients with Antithyroglobulin Antibodies. | Thyroid | 2017 |
| 28011713 | Germline compound heterozygous poly-glutamine deletion in USF3 may be involved in predisposition to heritable and sporadic epithelial thyroid carcinoma. | Hum Mol Genet | 2017 |
| 27459529 | Genome-Wide Expression Screening Discloses Long Noncoding RNAs Involved in Thyroid Carcinogenesis. | J Clin Endocrinol Metab | 2016 |
| 26549818 | Integrin-linked kinase affects signaling pathways and migration in thyroid cancer cells and is a potential therapeutic target. | Surgery | 2016 |
| 27533304 | Risk Factors of <sup>131</sup>I-Induced Salivary Gland Damage in Thyroid Cancer Patients. | J Clin Endocrinol Metab | 2016 |